Nav: Home

MorNuCo Inc. becomes first recipient of award for research and science innovation

June 09, 2016

Dallas, Texas - June 9th, 2016 - MorNuCo Laboratories of West Lafayette, Indiana and its founders, D. James Morré, PhD, and Dorothy M. Morré, PhD, recently received the first ever L. Stephen Coles, MD, PhD Award for Research and Science Innovation in Aging and Age Management Medicine at the AMMG Conference in Orlando Florida on May 14th. This award honors the excellence and significant contributions that MorNuCo Laboratories has worked to achieve since the beginning of their research , including ENOX2 and the ONCOblot® Test. MorNuCo is elated to share this award with the public as they continue to move forward in the fight against cancer.

The award's origin spurs from Dr. Stephen L. Coles, who was a remarkable physician and researcher, who dedicated much of his life to advancing the field of age management. Sadly, the scientific and medical communities lost Dr. Coles in November of 2014. In large part, this award pays homage to Dr. Coles as a shining example of an individual with a desire to drive scientific discovery.

Upon receiving this award, Dr. D. James Morré stated, "It is a true privilege to be recognized for this award given that it is named after such an impactful person to this field."

Undoubtedly the Morrés exemplify the spirit for which this honor is awarded; a passion for discovery and the highest ethics and scientific values in conducting research and innovation within the fields of aging and age management medicine.

With the advent of technologies like the ONCOblot® Test that the Morrés have dedicated their lives to developing, physicians are increasingly finding themselves better prepared to handle age related diseases, such as cancer.

The L. Stephen Coles, MD, PhD Award for Research and Science Innovation in Aging and Age Management Medicine serves as a reminder of how much effort is being put forth to eliminate age related diseases - including cancer. It is a hopeful milestone for a cancer-free future and a wonderful award to solidify decades of hard work by the Morrés.
-end-
About ONCOblot®

The ONCOblot® Test was developed and created by Dr. D. James Morré and Dr. Dorothy M. Morré of MorNuCo, Purdue Research Park, West Lafayette, IN. The Morrés are committed to the premise that understanding cancer is the key to its conquest. The ONCOblot® test is based on more than 20 years of basic research and confirms the presence of cancer and the tissue of origin through the detection of ENOX2.

If you'd like more information about the ONCOblot® Test, please visit http://www.oncoblotlabs.com or e-mail info@oncoblotlabs.com

ONCOblot Labs

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.